$INNV
InnovAge Holding Corp. Stock $innv

$innv Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-K Financial Statement

#000183437623000017 Filed on September 12, 2023

Income Statement

Concept	2023 Q3	2023 Q2	2023
Revenue	$182.5M	$176.9M	$688.1M
YoY Change	6.58%	2.32%	-1.51%
Cost Of Revenue	$154.6M	$148.4M	$586.8M
YoY Change	3.21%	-0.58%	4.18%
Gross Profit	$27.88M	$28.51M	$101.3M
YoY Change	30.12%	20.63%	-25.18%
Gross Profit Margin	15.28%	16.12%	14.72%
Selling, General & Admin	$34.33M	$35.12M	$135.3M
YoY Change	-0.77%	8.09%	7.48%
% of Gross Profit	123.13%	123.19%	133.54%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$4.269M	$4.332M	$15.42M
YoY Change	24.35%	24.16%	10.74%
% of Gross Profit	15.31%	15.2%	15.22%
Operating Expenses	$34.33M	$39.45M	$135.3M
YoY Change	-9.73%	9.64%	7.48%
Operating Profit	-$10.72M	-$10.94M	-$49.40M
YoY Change	-35.45%	-11.38%	1021.08%
Interest Expense	$661.0K	-$291.0K	-$1.522M
YoY Change	-209.62%	-51.17%	-160.25%
% of Operating Profit
Other Income/Expense, Net	-$18.00K	-$256.0K	-$1.398M
YoY Change	-148.65%	-583.02%	-50.62%
Pretax Income	-$10.70M	-$11.49M	-$50.79M
YoY Change	-37.68%	-10.87%	601.85%
Income Tax	$200.0K	$506.0K	-$7.241M
% Of Pretax Income
Net Earnings	-$10.30M	-$11.18M	-$40.67M
YoY Change	-21.18%	-12.05%	523.72%
Net Earnings / Revenue	-5.65%	-6.32%	-5.91%
Basic Earnings Per Share	-$0.08		-$0.30
Diluted Earnings Per Share	-$0.08	-$0.08	-$0.30
COMMON SHARES
Basic Shares Outstanding	135.9M shares	135.6M shares	135.6M shares
Diluted Shares Outstanding	135.8M shares		135.6M shares

Balance Sheet

Concept	2023 Q3	2023 Q2	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$223.6M	$300.7M	$173.5M
YoY Change	18.81%	63.05%	-5.95%
Cash & Equivalents	$88.40M	$127.2M	$127.2M
Short-Term Investments	$135.2M	$173.5M	$46.21M
Other Short-Term Assets	$16.40M	$17.16M	$17.16M
YoY Change	34.62%	23.83%	23.83%
Inventory
Prepaid Expenses	$16.41M	$17.15M
Receivables	$44.19M	$24.34M	$24.34M
Other Receivables	$200.0K	$262.0K	$262.0K
Total Short-Term Assets	$196.1M	$215.2M	$215.2M
YoY Change	-19.28%	-10.68%	-10.68%
LONG-TERM ASSETS
Property, Plant & Equipment	$210.5M	$213.4M	$213.4M
YoY Change	3.15%	21.07%	21.07%
Goodwill	$124.2M	$124.2M
YoY Change		-0.01%
Intangibles	$5.033M	$5.198M
YoY Change		-11.27%
Long-Term Investments	$848.0K	$848.0K	$5.493M
YoY Change	-84.56%	0.0%	0.0%
Other Assets	$4.200M	$3.823M	$3.823M
YoY Change	63.74%	35.95%	35.95%
Total Long-Term Assets	$349.5M	$352.1M	$352.1M
YoY Change	2.18%	11.91%	11.91%
TOTAL ASSETS
Total Short-Term Assets	$196.1M	$215.2M	$215.2M
Total Long-Term Assets	$349.5M	$352.1M	$352.1M
Total Assets	$545.6M	$567.4M	$567.4M
YoY Change	-6.73%	2.12%	2.12%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$46.90M	$54.94M	$54.94M
YoY Change	-7.78%	8.65%	8.65%
Accrued Expenses	$3.600M	$3.530M	$3.530M
YoY Change	5.26%
Deferred Revenue	$26.09M	$28.12M
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$3.795M	$3.795M	$8.517M
YoY Change	-47.06%	0.05%	18.94%
Total Short-Term Liabilities	$138.8M	$148.5M	$148.5M
YoY Change	5.63%	40.97%	40.97%
LONG-TERM LIABILITIES
Long-Term Debt	$64.00M	$64.84M	$77.96M
YoY Change	-15.96%	-4.93%	0.4%
Other Long-Term Liabilities	$1.141M	$1.086M	$19.91M
YoY Change	-94.78%	-4.23%	1656.08%
Total Long-Term Liabilities	$65.14M	$65.93M	$97.87M
YoY Change	-33.54%	-4.92%	24.23%
TOTAL LIABILITIES
Total Short-Term Liabilities	$138.8M	$148.5M	$148.5M
Total Long-Term Liabilities	$65.14M	$65.93M	$97.87M
Total Liabilities	$240.5M	$252.6M	$271.1M
YoY Change	-9.05%	25.12%	21.42%
SHAREHOLDERS EQUITY
Retained Earnings	-$46.25M	-$35.94M
YoY Change		-860.08%
Common Stock	$136.0K	$136.0K
YoY Change		0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$287.2M	$296.3M	$296.3M
YoY Change
Total Liabilities & Shareholders Equity	$545.6M	$567.4M	$567.4M
YoY Change	-6.73%	2.12%	2.12%

Cashflow Statement

Concept	2023 Q3	2023 Q2	2023
OPERATING ACTIVITIES
Net Income	-$10.30M	-$11.18M	-$40.67M
YoY Change	-21.18%	-12.05%	523.72%
Depreciation, Depletion And Amortization	$4.269M	$4.332M	$15.42M
YoY Change	24.35%	24.16%	10.74%
Cash From Operating Activities	-$32.99M	$13.15M	$20.24M
YoY Change	-351.28%	305.52%	-25.88%
INVESTING ACTIVITIES
Capital Expenditures	$2.571M	$4.025M	$23.35M
YoY Change	-133.54%	-124.16%	-38.92%
Acquisitions
YoY Change
Other Investing Activities	-$570.0K	-$1.167M	-$46.17M
YoY Change			2208.35%
Cash From Investing Activities	-$3.141M	-$5.192M	-$69.52M
YoY Change	-59.03%	-68.84%	72.77%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net	$948.0K		$3.793M
YoY Change	0.0%		0.08%
Cash From Financing Activities	-$2.726M	-2.416M	-$7.896M
YoY Change	63.43%	46.6%	24.98%
NET CHANGE
Cash From Operating Activities	-$32.99M	13.15M	$20.24M
Cash From Investing Activities	-$3.141M	-5.192M	-$69.52M
Cash From Financing Activities	-$2.726M	-2.416M	-$7.896M
Net Change In Cash	-$38.85M	5.543M	-$57.18M
YoY Change	-1124.31%	-136.79%	196.98%
FREE CASH FLOW
Cash From Operating Activities	-$32.99M	$13.15M	$20.24M
Capital Expenditures	$2.571M	$4.025M	$23.35M
Free Cash Flow	-$35.56M	$9.126M	-$3.118M
YoY Change	-271.0%	-54.15%	-71.49%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001834376
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023Q2	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-06-30
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	dei	Entity Public Float EntityPublicFloat	135500000	usd
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	135878031	shares
CY2023	dei	Auditor Firm AuditorFirmId	34
CY2023	dei	Auditor Name AuditorName	Deloitte & Touche LLP
CY2023	dei	Auditor Location AuditorLocation	Denver, CO
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	127249000	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	184429000	usd
CY2023Q2	us-gaap	Short Term Investments ShortTermInvestments	46213000	usd
CY2022Q2	us-gaap	Short Term Investments ShortTermInvestments	0	usd
CY2023Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	16000	usd
CY2022Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	17000	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	4161000	usd
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	3403000	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	24344000	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	35907000	usd
CY2023Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	17145000	usd
CY2022Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	13842000	usd
CY2023Q2	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	262000	usd
CY2022Q2	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	6761000	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	215229000	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	240956000	usd
CY2023Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	192188000	usd
CY2022Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	176260000	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	21210000	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	0	usd
CY2023Q2	us-gaap	Long Term Investments LongTermInvestments	5493000	usd
CY2022Q2	us-gaap	Long Term Investments LongTermInvestments	5493000	usd
CY2023Q2	innv	Deposits And Other Assets Noncurrent DepositsAndOtherAssetsNoncurrent	3823000	usd
CY2022Q2	innv	Deposits And Other Assets Noncurrent DepositsAndOtherAssetsNoncurrent	2812000	usd
CY2023Q2	us-gaap	Goodwill Goodwill	124217000	usd
CY2022Q2	us-gaap	Goodwill Goodwill	124217000	usd
CY2023Q2	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	5198000	usd
CY2022Q2	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	5858000	usd
CY2023Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	352129000	usd
CY2022Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	314640000	usd
CY2023Q2	us-gaap	Assets Assets	567358000	usd
CY2022Q2	us-gaap	Assets Assets	555596000	usd
CY2023Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	54935000	usd
CY2022Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	50562000	usd
CY2023Q2	innv	Reported And Estimated Claims Current ReportedAndEstimatedClaimsCurrent	42999000	usd
CY2022Q2	innv	Reported And Estimated Claims Current ReportedAndEstimatedClaimsCurrent	38454000	usd
CY2023Q2	innv	Due To State And Federal Health Programs DueToStateAndFederalHealthPrograms	9142000	usd
CY2022Q2	innv	Due To State And Federal Health Programs DueToStateAndFederalHealthPrograms	9130000	usd
CY2023Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	1212000	usd
CY2022Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	0	usd
CY2023Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	3795000	usd
CY2022Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	3793000	usd
CY2023Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	4722000	usd
CY2022Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	3368000	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3530000	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	0	usd
CY2023Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	28115000	usd
CY2022Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	0	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	148450000	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	105307000	usd
CY2023Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	6236000	usd
CY2022Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	17761000	usd
CY2023Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	13114000	usd
CY2022Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	9440000	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	18828000	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	usd
CY2023Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1086000	usd
CY2022Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1134000	usd
CY2023Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	64844000	usd
CY2022Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	68210000	usd
CY2023Q2	us-gaap	Liabilities Liabilities	252558000	usd
CY2022Q2	us-gaap	Liabilities Liabilities	201852000	usd
CY2023Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q2	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	12708000	usd
CY2022Q2	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	15278000	usd
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	135639845	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	135532811	shares
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	136000	usd
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	136000	usd
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	327499000	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	4729000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	332364000	usd
CY2022Q2	us-gaap	Minority Interest MinorityInterest	6102000	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	338466000	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	555596000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	698640000	usd
CY2022	innv	External Provider Costs ExternalProviderCosts	383046000	usd
CY2022	us-gaap	Direct Operating Costs DirectOperatingCosts	180222000	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	24201000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	101653000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-4406000	usd
CY2022	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-2526000	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	124000	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-305000	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1398000	usd
CY2023	us-gaap	Income Loss Including Portion Attributable To Noncontrolling Interest IncomeLossIncludingPortionAttributableToNoncontrollingInterest	-50793000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-7241000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-43552000	usd
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-2879000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-40673000	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	135593824	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	135593824	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.30
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.30
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	340979000	usd
CY2021Q2	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	16986000	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	3739000	usd
CY2022	innv	Adjustment To Redemption Value AdjustmentToRedemptionValue	-587000	usd
CY2022	us-gaap	Temporary Equity Other Changes TemporaryEquityOtherChanges	-587000	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	338466000	usd
CY2022Q2	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	15278000	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	338466000	usd
CY2022Q2	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	15278000	usd
CY2023	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	4608000	usd
CY2023	innv	Adjustment To Redemption Value AdjustmentToRedemptionValue	0	usd
CY2023	us-gaap	Temporary Equity Other Changes TemporaryEquityOtherChanges	0	usd
CY2023	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	-40982000	usd
CY2023	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	-2570000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-43552000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	302092000	usd
CY2023Q2	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	12708000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-43552000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-7960000	usd
CY2023	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-1107000	usd
CY2022	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-305000	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	3340000	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	6181000	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	15419000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	13924000	usd
CY2023	us-gaap	Operating Lease Expense OperatingLeaseExpense	4604000	usd
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	0	usd
CY2023	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	429000	usd
CY2022	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	429000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	4608000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	3739000	usd
CY2023	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-11525000	usd
CY2022	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	2061000	usd
CY2023	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	167000	usd
CY2022	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	0	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-8223000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	9506000	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3303000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	4667000	usd
CY2023	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-6499000	usd
CY2022	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	1360000	usd
CY2023	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	1263000	usd
CY2022	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	475000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	34901000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	17381000	usd
CY2023	innv	Increase Decrease In Reported And Estimated Claims IncreaseDecreaseInReportedAndEstimatedClaims	4545000	usd
CY2022	innv	Increase Decrease In Reported And Estimated Claims IncreaseDecreaseInReportedAndEstimatedClaims	5221000	usd
CY2023	innv	Increase Decrease In Due To State And Federal Health Programs IncreaseDecreaseInDueToStateAndFederalHealthPrograms	12000	usd
CY2022	innv	Increase Decrease In Due To State And Federal Health Programs IncreaseDecreaseInDueToStateAndFederalHealthPrograms	2029000	usd
CY2023	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	1212000	usd
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	0	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-5187000	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	0	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	20236000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	27302000	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	23354000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	38238000	usd
CY2023	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	46167000	usd
CY2022	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	0	usd
CY2023	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	0	usd
CY2022	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	2000000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-69521000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-40238000	usd
CY2023	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	4103000	usd
CY2022	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	2528000	usd
CY2023	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	3793000	usd
CY2022	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	3790000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-7896000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-6318000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-57181000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-19254000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	184446000	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	203700000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	127265000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	184446000	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	3997000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	1474000	usd
CY2023	us-gaap	Income Taxes Paid IncomeTaxesPaid	13000	usd
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid	84000	usd
CY2023	innv	Property And Equipment Included In Accounts Payable PropertyAndEquipmentIncludedInAccountsPayable	882000	usd
CY2022	innv	Property And Equipment Included In Accounts Payable PropertyAndEquipmentIncludedInAccountsPayable	2135000	usd
CY2023	innv	Property And Equipment Purchased Under Capital Leases PropertyAndEquipmentPurchasedUnderCapitalLeases	9131000	usd
CY2022	innv	Property And Equipment Purchased Under Capital Leases PropertyAndEquipmentPurchasedUnderCapitalLeases	8067000	usd
CY2023	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2023	innv	Number Of Participants NumberOfParticipants	6400	participant
CY2023	innv	Number Of Centers Excluding Non Consolidating Joint Ventures NumberOfCentersExcludingNonConsolidatingJointVentures	17	center
CY2023	innv	Percentage Of Health Care Costs Incurred PercentageOfHealthCareCostsIncurred	1
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Estimates are used in accounting for, among other things, the allowance for uncollectible accounts; useful lives of property and equipment and the valuation of goodwill and intangible assets; risk-score adjustments to participant revenues; reported and estimated claims; accruals; the determination of assumptions for stock-based compensation costs; deferred taxes, including the determination of a need for a valuation allowance; legal contingencies, including medical malpractice claims; the determination of fair value of net assets acquired in a business combination; and other fair value measurements. Actual results may differ from previously estimated amounts.</span></div>
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	0	usd
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	0	usd
CY2023Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	262865000	usd
CY2022Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	233345000	usd
CY2023Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	70677000	usd
CY2022Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	57085000	usd
CY2023Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	192188000	usd
CY2022Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	176260000	usd
CY2023	us-gaap	Depreciation Depreciation	14800000	usd
CY2022	us-gaap	Depreciation Depreciation	13300000	usd
CY2023Q2	us-gaap	Accumulated Capitalized Interest Costs AccumulatedCapitalizedInterestCosts	1000000	usd
CY2022Q2	us-gaap	Accumulated Capitalized Interest Costs AccumulatedCapitalizedInterestCosts	900000	usd
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2023	us-gaap	Number Of Reporting Units NumberOfReportingUnits	3	reporting_unit
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2022Q2	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P10Y
CY2023Q2	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P10Y
CY2023	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2023	us-gaap	Advertising Expense AdvertisingExpense	5600000	usd
CY2022	us-gaap	Advertising Expense AdvertisingExpense	6700000	usd
CY2023	innv	Percentage Of Pooled Capitated Payment Received PercentageOfPooledCapitatedPaymentReceived	1
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	4200000	usd
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	3400000	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	700000	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	60052000	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	56000	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	60000	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	2021000	usd
CY2023Q2	innv	Cost Method Investment CostMethodInvestment	4645000	usd
CY2022Q2	innv	Cost Method Investment CostMethodInvestment	4645000	usd
CY2023Q2	us-gaap	Equity Method Investments EquityMethodInvestments	848000	usd
CY2022Q2	us-gaap	Equity Method Investments EquityMethodInvestments	848000	usd
CY2023Q2	us-gaap	Long Term Investments LongTermInvestments	5493000	usd
CY2022Q2	us-gaap	Long Term Investments LongTermInvestments	5493000	usd
CY2023Q2	innv	Number Of Investments Accounted Under Cost Method NumberOfInvestmentsAccountedUnderCostMethod	2	investment
CY2023	innv	Equity Securities Increase Decrease From Observable Price Changes EquitySecuritiesIncreaseDecreaseFromObservablePriceChanges	0	usd
CY2022	innv	Equity Securities Increase Decrease From Observable Price Changes EquitySecuritiesIncreaseDecreaseFromObservablePriceChanges	0	usd
CY2019Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9000000	usd
CY2019Q1	us-gaap	Land Land	4200000	usd
CY2023Q2	us-gaap	Redeemable Noncontrolling Interest Equity Fair Value RedeemableNoncontrollingInterestEquityFairValue	12700000	usd
CY2023Q2	us-gaap	Goodwill Goodwill	124200000	usd
CY2022Q2	us-gaap	Goodwill Goodwill	124200000	usd
CY2022	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	0	usd
CY2023	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	0	usd
CY2023	us-gaap	Number Of Reporting Units NumberOfReportingUnits	3	reporting_unit
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	6600000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	6600000	usd
CY2023Q2	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	2000000	usd
CY2022Q2	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	2000000	usd
CY2023Q2	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	8600000	usd
CY2022Q2	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	8600000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3402000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	2742000	usd
CY2023Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	5198000	usd
CY2022Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	5858000	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	700000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	660000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	660000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	660000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	630000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	0	usd
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2023	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2023Q1	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	600000	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	21210000	usd
CY2023Q2	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	16378000	usd
CY2023Q2	innv	Right Of Use Asset RightOfUseAsset	37588000	usd
CY2023	us-gaap	Lease Cost LeaseCost	9167000	usd
CY2023Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y10M24D
CY2023Q2	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P3Y10M24D
CY2023Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0660
CY2023Q2	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0780
CY2022Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	68210000	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	3796000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	4882000	usd
CY2023Q2	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	5970000	usd
CY2023Q2	innv	Lease Liability Payments Due Year One LeaseLiabilityPaymentsDueYearOne	10852000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	4356000	usd
CY2023Q2	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	5270000	usd
CY2023Q2	innv	Lease Liability Payments Due Year Two LeaseLiabilityPaymentsDueYearTwo	9626000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	4283000	usd
CY2023Q2	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	4245000	usd
CY2023Q2	innv	Lease Liability Payments Due Year Three LeaseLiabilityPaymentsDueYearThree	8528000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	3981000	usd
CY2023Q2	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	3549000	usd
CY2023Q2	innv	Lease Liability Payments Due Year Four LeaseLiabilityPaymentsDueYearFour	7530000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	3140000	usd
CY2023Q2	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	1759000	usd
CY2023Q2	innv	Lease Liability Payments Due Year Five LeaseLiabilityPaymentsDueYearFive	4899000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	7033000	usd
CY2023Q2	us-gaap	Finance Lease Liability Payments Due After Year Five FinanceLeaseLiabilityPaymentsDueAfterYearFive	0	usd
CY2023Q2	innv	Lease Liability Payments Due After Year Five LeaseLiabilityPaymentsDueAfterYearFive	7033000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	27675000	usd
CY2023Q2	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	20793000	usd
CY2023Q2	innv	Lease Liability Payments Due LeaseLiabilityPaymentsDue	48468000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	5317000	usd
CY2023Q2	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	2957000	usd
CY2023Q2	innv	Lease Liability Undiscounted Excess Amount LeaseLiabilityUndiscountedExcessAmount	8274000	usd
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	22358000	usd
CY2023Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	17836000	usd
CY2023Q2	innv	Lease Liability LeaseLiability	40194000	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3530000	usd
CY2023Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	4722000	usd
CY2023Q2	innv	Lease Liability Current LeaseLiabilityCurrent	8252000	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	18828000	usd
CY2023Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	13114000	usd
CY2023Q2	innv	Lease Liability Noncurrent LeaseLiabilityNoncurrent	31942000	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	3799000	usd
CY2022Q2	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	4873000	usd
CY2022Q2	us-gaap	Capital Leases Future Minimum Payments Due Current CapitalLeasesFutureMinimumPaymentsDueCurrent	4405000	usd
CY2022Q2	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	4581000	usd
CY2022Q2	us-gaap	Capital Leases Future Minimum Payments Due In Two Years CapitalLeasesFutureMinimumPaymentsDueInTwoYears	3909000	usd
CY2022Q2	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	4122000	usd
CY2022Q2	us-gaap	Capital Leases Future Minimum Payments Due In Three Years CapitalLeasesFutureMinimumPaymentsDueInThreeYears	3126000	usd
CY2022Q2	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	4061000	usd
CY2022Q2	us-gaap	Capital Leases Future Minimum Payments Due In Four Years CapitalLeasesFutureMinimumPaymentsDueInFourYears	2092000	usd
CY2022Q2	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	3764000	usd
CY2022Q2	us-gaap	Capital Leases Future Minimum Payments Due In Five Years CapitalLeasesFutureMinimumPaymentsDueInFiveYears	1393000	usd
CY2022Q2	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	10265000	usd
CY2022Q2	us-gaap	Capital Leases Future Minimum Payments Due Thereafter CapitalLeasesFutureMinimumPaymentsDueThereafter	535000	usd
CY2022Q2	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	31666000	usd
CY2022Q2	us-gaap	Capital Leases Future Minimum Payments Due CapitalLeasesFutureMinimumPaymentsDue	15460000	usd
CY2022Q2	us-gaap	Capital Leases Future Minimum Payments Interest Included In Payments CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments	2652000	usd
CY2022Q2	us-gaap	Capital Leases Future Minimum Payments Present Value Of Net Minimum Payments CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments	12808000	usd
CY2022Q2	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	3368000	usd
CY2022Q2	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	9440000	usd
CY2023Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	69784000	usd
CY2022Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	73577000	usd
CY2023Q2	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	1145000	usd
CY2022Q2	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	1574000	usd
CY2023Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	3795000	usd
CY2022Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	3793000	usd
CY2023Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	64844000	usd
CY2023Q2	us-gaap	Long Term Debt LongTermDebt	69784000	usd
CY2023Q2	innv	Marketable Securities Amortized Cost MarketableSecuritiesAmortizedCost	173419000	usd
CY2023Q2	us-gaap	Marketable Securities MarketableSecurities	173462000	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	127249000	usd
CY2023Q2	innv	Short Term Investments Fair Value Disclosure ShortTermInvestmentsFairValueDisclosure	46213000	usd
CY2023Q1	us-gaap	Litigation Settlement Amount Awarded To Other Party LitigationSettlementAmountAwardedToOtherParty	1200000	usd
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4993000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3739000	usd
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.143
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.100
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-10667000	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-1520000	usd
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	588000	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	506000	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	4297000	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	2738000	usd
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	457000	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	662000	usd
CY2023	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes	157000	usd
CY2022	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes	389000	usd
CY2023	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome	-605000	usd
CY2022	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome	-302000	usd
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-2678000	usd
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-2354000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-7241000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	723000	usd
CY2023	innv	Number Of Officers Highest Compensation Paid NumberOfOfficersHighestCompensationPaid	5	officer
CY2023	innv	Effective Income Tax Rate Reconciliation Nondeductible Expense Compensation Paid EffectiveIncomeTaxRateReconciliationNondeductibleExpenseCompensationPaid	1000000	usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	3709000	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-998000	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	575000	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-339000	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	4284000	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-1337000	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-10263000	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	1408000	usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-1262000	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	652000	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-11525000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	2060000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-7241000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	723000	usd
CY2023Q2	innv	Deferred Tax Assets Amortization DeferredTaxAssetsAmortization	629000	usd
CY2022Q2	innv	Deferred Tax Assets Amortization DeferredTaxAssetsAmortization	686000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	17147000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	3083000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	5701000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	4048000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	1114000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	869000	usd
CY2023Q2	innv	Deferred Tax Assets Accrued Vacation DeferredTaxAssetsAccruedVacation	835000	usd
CY2022Q2	innv	Deferred Tax Assets Accrued Vacation DeferredTaxAssetsAccruedVacation	828000	usd
CY2023Q2	innv	Deferred Tax Assets Reported And Estimated Claims DeferredTaxAssetsReportedAndEstimatedClaims	1164000	usd
CY2022Q2	innv	Deferred Tax Assets Reported And Estimated Claims DeferredTaxAssetsReportedAndEstimatedClaims	1025000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	449000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	185000	usd
CY2023Q2	innv	Deferred Tax Assets Accrued Bonuses DeferredTaxAssetsAccruedBonuses	582000	usd
CY2022Q2	innv	Deferred Tax Assets Accrued Bonuses DeferredTaxAssetsAccruedBonuses	102000	usd
CY2023Q2	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	791000	usd
CY2022Q2	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	496000	usd
CY2023Q2	innv	Deferred Tax Asset Lease Liability DeferredTaxAssetLeaseLiability	6784000	usd
CY2022Q2	innv	Deferred Tax Asset Lease Liability DeferredTaxAssetLeaseLiability	0	usd
CY2023Q2	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	0	usd
CY2022Q2	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	6000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	35196000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	11328000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	8347000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	4050000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	26849000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	7278000	usd
CY2023Q2	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill	6697000	usd
CY2022Q2	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill	9108000	usd
CY2023Q2	innv	Deferred Tax Liabilities Depreciation DeferredTaxLiabilitiesDepreciation	13137000	usd
CY2022Q2	innv	Deferred Tax Liabilities Depreciation DeferredTaxLiabilitiesDepreciation	8430000	usd
CY2023Q2	innv	Deferred Tax Liabilities Equity Method Investments DeferredTaxLiabilitiesEquityMethodInvestments	5019000	usd
CY2022Q2	innv	Deferred Tax Liabilities Equity Method Investments DeferredTaxLiabilitiesEquityMethodInvestments	5429000	usd
CY2023Q2	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	1792000	usd
CY2022Q2	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	2072000	usd
CY2023Q2	innv	Deferred Tax Liabilities Rights Of Use Of Asset DeferredTaxLiabilitiesRightsOfUseOfAsset	6436000	usd
CY2022Q2	innv	Deferred Tax Liabilities Rights Of Use Of Asset DeferredTaxLiabilitiesRightsOfUseOfAsset	0	usd
CY2023Q2	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	4000	usd
CY2022Q2	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	0	usd
CY2023Q2	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	33085000	usd
CY2022Q2	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	25039000	usd
CY2023Q2	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	6236000	usd
CY2022Q2	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	17761000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	8300000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	4100000	usd
CY2023Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2022Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	5	segment
CY2023	innv	Number Of Participants NumberOfParticipants	6400	participant
CY2023	innv	Number Of Centers Excluding Non Consolidating Joint Ventures NumberOfCentersExcludingNonConsolidatingJointVentures	17	center
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	688087000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	698640000	usd
CY2023	innv	External Provider Costs ExternalProviderCosts	374528000	usd
CY2022	innv	External Provider Costs ExternalProviderCosts	383046000	usd
CY2023	us-gaap	Direct Operating Costs DirectOperatingCosts	212271000	usd
CY2022	us-gaap	Direct Operating Costs DirectOperatingCosts	180222000	usd
CY2023	us-gaap	Gross Profit GrossProfit	101288000	usd
CY2022	us-gaap	Gross Profit GrossProfit	135372000	usd
CY2023	us-gaap	Cost Of Goods And Services Sold Overhead CostOfGoodsAndServicesSoldOverhead	135264000	usd
CY2022	us-gaap	Cost Of Goods And Services Sold Overhead CostOfGoodsAndServicesSoldOverhead	125854000	usd
CY2023	us-gaap	Cost Of Goods And Services Sold Depreciation And Amortization CostOfGoodsAndServicesSoldDepreciationAndAmortization	15419000	usd
CY2022	us-gaap	Cost Of Goods And Services Sold Depreciation And Amortization CostOfGoodsAndServicesSoldDepreciationAndAmortization	13924000	usd
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	usd
CY2023	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	0	usd
CY2022	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	0	usd
CY2023	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-1522000	usd
CY2022	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-2526000	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2023	us-gaap	Equity Method Investment Realized Gain Loss On Disposal EquityMethodInvestmentRealizedGainLossOnDisposal	0	usd
CY2022	us-gaap	Equity Method Investment Realized Gain Loss On Disposal EquityMethodInvestmentRealizedGainLossOnDisposal	0	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	124000	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-305000	usd
CY2023	us-gaap	Income Loss Including Portion Attributable To Noncontrolling Interest IncomeLossIncludingPortionAttributableToNoncontrollingInterest	-50793000	usd
CY2022	us-gaap	Income Loss Including Portion Attributable To Noncontrolling Interest IncomeLossIncludingPortionAttributableToNoncontrollingInterest	-7237000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-40673000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-6521000	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	135593824	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	135519970	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.30
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
CY2023	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2022	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	135593824	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	135519970	shares
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.30
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
CY2023Q2	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001834376-23-000017-index-headers.html	Edgar Link	pending
0001834376-23-000017-index.html	Edgar Link	pending
0001834376-23-000017.txt	Edgar Link	pending
0001834376-23-000017-xbrl.zip	Edgar Link	pending
ex1020-active_84672814x9.htm	Edgar Link	pending
ex1020-active_84672814x9001.jpg	Edgar Link	pending
ex1020-active_84672814x9002.jpg	Edgar Link	pending
ex1020-active_84672814x9003.jpg	Edgar Link	pending
ex1020-active_84672814x9004.jpg	Edgar Link	pending
ex1020-active_84672814x9005.jpg	Edgar Link	pending
ex1020-active_84672814x9006.jpg	Edgar Link	pending
ex1020-active_84672814x9007.jpg	Edgar Link	pending
ex1020-active_84672814x9008.jpg	Edgar Link	pending
ex1020-active_84672814x9009.jpg	Edgar Link	pending
ex103-innovagexamendment.htm	Edgar Link	pending
ex103-innovagexamendment001.jpg	Edgar Link	pending
ex103-innovagexamendment002.jpg	Edgar Link	pending
ex103-innovagexamendment003.jpg	Edgar Link	pending
ex103-innovagexamendment004.jpg	Edgar Link	pending
ex103-innovagexamendment005.jpg	Edgar Link	pending
ex103-innovagexamendment006.jpg	Edgar Link	pending
ex103-innovagexamendment007.jpg	Edgar Link	pending
ex103-innovagexamendment008.jpg	Edgar Link	pending
ex103-innovagexamendment009.jpg	Edgar Link	pending
ex103-innovagexamendment010.jpg	Edgar Link	pending
ex103-innovagexamendment011.jpg	Edgar Link	pending
ex103-innovagexamendment012.jpg	Edgar Link	pending
ex103-innovagexamendment013.jpg	Edgar Link	pending
ex103-innovagexamendment014.jpg	Edgar Link	pending
ex103-innovagexamendment015.jpg	Edgar Link	pending
ex103-innovagexamendment016.jpg	Edgar Link	pending
ex103-innovagexamendment017.jpg	Edgar Link	pending
ex103-innovagexamendment018.jpg	Edgar Link	pending
ex103-innovagexamendment019.jpg	Edgar Link	pending
ex103-innovagexamendment020.jpg	Edgar Link	pending
ex103-innovagexamendment021.jpg	Edgar Link	pending
ex103-innovagexamendment022.jpg	Edgar Link	pending
ex103-innovagexamendment023.jpg	Edgar Link	pending
ex103-innovagexamendment024.jpg	Edgar Link	pending
ex103-innovagexamendment025.jpg	Edgar Link	pending
ex103-innovagexamendment026.jpg	Edgar Link	pending
ex103-innovagexamendment027.jpg	Edgar Link	pending
ex103-innovagexamendment028.jpg	Edgar Link	pending
ex103-innovagexamendment029.jpg	Edgar Link	pending
ex103-innovagexamendment030.jpg	Edgar Link	pending
ex103-innovagexamendment031.jpg	Edgar Link	pending
ex103-innovagexamendment032.jpg	Edgar Link	pending
ex103-innovagexamendment033.jpg	Edgar Link	pending
ex103-innovagexamendment034.jpg	Edgar Link	pending
ex103-innovagexamendment035.jpg	Edgar Link	pending
ex103-innovagexamendment036.jpg	Edgar Link	pending
ex103-innovagexamendment037.jpg	Edgar Link	pending
ex103-innovagexamendment038.jpg	Edgar Link	pending
ex103-innovagexamendment039.jpg	Edgar Link	pending
ex103-innovagexamendment040.jpg	Edgar Link	pending
ex103-innovagexamendment041.jpg	Edgar Link	pending
ex103-innovagexamendment042.jpg	Edgar Link	pending
ex103-innovagexamendment043.jpg	Edgar Link	pending
ex103-innovagexamendment044.jpg	Edgar Link	pending
ex103-innovagexamendment045.jpg	Edgar Link	pending
ex103-innovagexamendment046.jpg	Edgar Link	pending
ex103-innovagexamendment047.jpg	Edgar Link	pending
ex103-innovagexamendment048.jpg	Edgar Link	pending
ex103-innovagexamendment049.jpg	Edgar Link	pending
ex103-innovagexamendment050.jpg	Edgar Link	pending
ex103-innovagexamendment051.jpg	Edgar Link	pending
ex103-innovagexamendment052.jpg	Edgar Link	pending
ex103-innovagexamendment053.jpg	Edgar Link	pending
ex103-innovagexamendment054.jpg	Edgar Link	pending
ex103-innovagexamendment055.jpg	Edgar Link	pending
ex103-innovagexamendment056.jpg	Edgar Link	pending
ex103-innovagexamendment057.jpg	Edgar Link	pending
ex103-innovagexamendment058.jpg	Edgar Link	pending
ex103-innovagexamendment059.jpg	Edgar Link	pending
ex103-innovagexamendment060.jpg	Edgar Link	pending
ex103-innovagexamendment061.jpg	Edgar Link	pending
ex103-innovagexamendment062.jpg	Edgar Link	pending
ex103-innovagexamendment063.jpg	Edgar Link	pending
ex103-innovagexamendment064.jpg	Edgar Link	pending
ex103-innovagexamendment065.jpg	Edgar Link	pending
ex103-innovagexamendment066.jpg	Edgar Link	pending
ex103-innovagexamendment067.jpg	Edgar Link	pending
ex103-innovagexamendment068.jpg	Edgar Link	pending
ex103-innovagexamendment069.jpg	Edgar Link	pending
ex103-innovagexamendment070.jpg	Edgar Link	pending
ex103-innovagexamendment071.jpg	Edgar Link	pending
ex103-innovagexamendment072.jpg	Edgar Link	pending
ex103-innovagexamendment073.jpg	Edgar Link	pending
ex103-innovagexamendment074.jpg	Edgar Link	pending
ex103-innovagexamendment075.jpg	Edgar Link	pending
ex103-innovagexamendment076.jpg	Edgar Link	pending
ex103-innovagexamendment077.jpg	Edgar Link	pending
ex103-innovagexamendment078.jpg	Edgar Link	pending
ex103-innovagexamendment079.jpg	Edgar Link	pending
ex103-innovagexamendment080.jpg	Edgar Link	pending
ex103-innovagexamendment081.jpg	Edgar Link	pending
ex103-innovagexamendment082.jpg	Edgar Link	pending
ex103-innovagexamendment083.jpg	Edgar Link	pending
ex103-innovagexamendment084.jpg	Edgar Link	pending
ex103-innovagexamendment085.jpg	Edgar Link	pending
ex103-innovagexamendment086.jpg	Edgar Link	pending
ex103-innovagexamendment087.jpg	Edgar Link	pending
ex103-innovagexamendment088.jpg	Edgar Link	pending
ex103-innovagexamendment089.jpg	Edgar Link	pending
ex103-innovagexamendment090.jpg	Edgar Link	pending
ex103-innovagexamendment091.jpg	Edgar Link	pending
ex103-innovagexamendment092.jpg	Edgar Link	pending
ex103-innovagexamendment093.jpg	Edgar Link	pending
ex103-innovagexamendment094.jpg	Edgar Link	pending
ex103-innovagexamendment095.jpg	Edgar Link	pending
ex103-innovagexamendment096.jpg	Edgar Link	pending
ex103-innovagexamendment097.jpg	Edgar Link	pending
ex103-innovagexamendment098.jpg	Edgar Link	pending
ex103-innovagexamendment099.jpg	Edgar Link	pending
ex103-innovagexamendment100.jpg	Edgar Link	pending
ex103-innovagexamendment101.jpg	Edgar Link	pending
ex103-innovagexamendment102.jpg	Edgar Link	pending
ex103-innovagexamendment103.jpg	Edgar Link	pending
ex103-innovagexamendment104.jpg	Edgar Link	pending
ex103-innovagexamendment105.jpg	Edgar Link	pending
ex103-innovagexamendment106.jpg	Edgar Link	pending
ex103-innovagexamendment107.jpg	Edgar Link	pending
ex103-innovagexamendment108.jpg	Edgar Link	pending
ex103-innovagexamendment109.jpg	Edgar Link	pending
ex103-innovagexamendment110.jpg	Edgar Link	pending
ex103-innovagexamendment111.jpg	Edgar Link	pending
ex103-innovagexamendment112.jpg	Edgar Link	pending
ex103-innovagexamendment113.jpg	Edgar Link	pending
ex103-innovagexamendment114.jpg	Edgar Link	pending
ex103-innovagexamendment115.jpg	Edgar Link	pending
ex103-innovagexamendment116.jpg	Edgar Link	pending
ex103-innovagexamendment117.jpg	Edgar Link	pending
ex103-innovagexamendment118.jpg	Edgar Link	pending
ex103-innovagexamendment119.jpg	Edgar Link	pending
ex103-innovagexamendment120.jpg	Edgar Link	pending
ex103-innovagexamendment121.jpg	Edgar Link	pending
ex103-innovagexamendment122.jpg	Edgar Link	pending
ex103-innovagexamendment123.jpg	Edgar Link	pending
ex103-innovagexamendment124.jpg	Edgar Link	pending
ex103-innovagexamendment125.jpg	Edgar Link	pending
ex103-innovagexamendment126.jpg	Edgar Link	pending
ex103-innovagexamendment127.jpg	Edgar Link	pending
ex103-innovagexamendment128.jpg	Edgar Link	pending
ex103-innovagexamendment129.jpg	Edgar Link	pending
ex103-innovagexamendment130.jpg	Edgar Link	pending
ex103-innovagexamendment131.jpg	Edgar Link	pending
ex103-innovagexamendment132.jpg	Edgar Link	pending
ex103-innovagexamendment133.jpg	Edgar Link	pending
ex103-innovagexamendment134.jpg	Edgar Link	pending
ex103-innovagexamendment135.jpg	Edgar Link	pending
ex103-innovagexamendment136.jpg	Edgar Link	pending
ex103-innovagexamendment137.jpg	Edgar Link	pending
ex103-innovagexamendment138.jpg	Edgar Link	pending
ex103-innovagexamendment139.jpg	Edgar Link	pending
ex103-innovagexamendment140.jpg	Edgar Link	pending
ex103-innovagexamendment141.jpg	Edgar Link	pending
ex103-innovagexamendment142.jpg	Edgar Link	pending
ex103-innovagexamendment143.jpg	Edgar Link	pending
ex103-innovagexamendment144.jpg	Edgar Link	pending
ex103-innovagexamendment145.jpg	Edgar Link	pending
ex103-innovagexamendment146.jpg	Edgar Link	pending
ex103-innovagexamendment147.jpg	Edgar Link	pending
ex103-innovagexamendment148.jpg	Edgar Link	pending
ex103-innovagexamendment149.jpg	Edgar Link	pending
ex103-innovagexamendment150.jpg	Edgar Link	pending
ex103-innovagexamendment151.jpg	Edgar Link	pending
ex103-innovagexamendment152.jpg	Edgar Link	pending
ex103-innovagexamendment153.jpg	Edgar Link	pending
ex103-innovagexamendment154.jpg	Edgar Link	pending
ex103-innovagexamendment155.jpg	Edgar Link	pending
ex103-innovagexamendment156.jpg	Edgar Link	pending
ex103-innovagexamendment157.jpg	Edgar Link	pending
ex103-innovagexamendment158.jpg	Edgar Link	pending
ex103-innovagexamendment159.jpg	Edgar Link	pending
ex103-innovagexamendment160.jpg	Edgar Link	pending
ex103-innovagexamendment161.jpg	Edgar Link	pending
ex103-innovagexamendment162.jpg	Edgar Link	pending
ex103-innovagexamendment163.jpg	Edgar Link	pending
ex103-innovagexamendment164.jpg	Edgar Link	pending
ex103-innovagexamendment165.jpg	Edgar Link	pending
ex103-innovagexamendment166.jpg	Edgar Link	pending
ex103-innovagexamendment167.jpg	Edgar Link	pending
ex103-innovagexamendment168.jpg	Edgar Link	pending
ex103-innovagexamendment169.jpg	Edgar Link	pending
ex103-innovagexamendment170.jpg	Edgar Link	pending
ex103-innovagexamendment171.jpg	Edgar Link	pending
ex103-innovagexamendment172.jpg	Edgar Link	pending
ex103-innovagexamendment173.jpg	Edgar Link	pending
ex103-innovagexamendment174.jpg	Edgar Link	pending
ex103-innovagexamendment175.jpg	Edgar Link	pending
ex103-innovagexamendment176.jpg	Edgar Link	pending
ex103-innovagexamendment177.jpg	Edgar Link	pending
ex103-innovagexamendment178.jpg	Edgar Link	pending
ex103-innovagexamendment179.jpg	Edgar Link	pending
ex103-innovagexamendment180.jpg	Edgar Link	pending
ex103-innovagexamendment181.jpg	Edgar Link	pending
ex103-innovagexamendment182.jpg	Edgar Link	pending
ex103-innovagexamendment183.jpg	Edgar Link	pending
ex103-innovagexamendment184.jpg	Edgar Link	pending
ex103-innovagexamendment185.jpg	Edgar Link	pending
ex103-innovagexamendment186.jpg	Edgar Link	pending
ex103-innovagexamendment187.jpg	Edgar Link	pending
ex103-innovagexamendment188.jpg	Edgar Link	pending
ex103-innovagexamendment189.jpg	Edgar Link	pending
ex103-innovagexamendment190.jpg	Edgar Link	pending
ex103-innovagexamendment191.jpg	Edgar Link	pending
ex103-innovagexamendment192.jpg	Edgar Link	pending
ex103-innovagexamendment193.jpg	Edgar Link	pending
ex103-innovagexamendment194.jpg	Edgar Link	pending
ex103-innovagexamendment195.jpg	Edgar Link	pending
ex103-innovagexamendment196.jpg	Edgar Link	pending
ex103-innovagexamendment197.jpg	Edgar Link	pending
ex103-innovagexamendment198.jpg	Edgar Link	pending
ex103-innovagexamendment199.jpg	Edgar Link	pending
ex103-innovagexamendment200.jpg	Edgar Link	pending
ex103-innovagexamendment201.jpg	Edgar Link	pending
ex103-innovagexamendment202.jpg	Edgar Link	pending
ex103-innovagexamendment203.jpg	Edgar Link	pending
ex103-innovagexamendment204.jpg	Edgar Link	pending
ex103-innovagexamendment205.jpg	Edgar Link	pending
ex103-innovagexamendment206.jpg	Edgar Link	pending
ex103-innovagexamendment207.jpg	Edgar Link	pending
ex103-innovagexamendment208.jpg	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
innv-20230630.htm	Edgar Link	pending
innv-20230630.xsd	Edgar Link	pending
innv-20230630xex21.htm	Edgar Link	pending
innv-20230630xex23.htm	Edgar Link	pending
innv-20230630xex311.htm	Edgar Link	pending
innv-20230630xex312.htm	Edgar Link	pending
innv-20230630xex321.htm	Edgar Link	pending
innv-20230630xex322.htm	Edgar Link	pending
innv-20230630_g1.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
innv-20230630_cal.xml	Edgar Link	unprocessable
innv-20230630_lab.xml	Edgar Link	unprocessable
innv-20230630_pre.xml	Edgar Link	unprocessable
innv-20230630_htm.xml	Edgar Link	completed
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
innv-20230630_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$INNV
InnovAge Holding Corp. Stock $innv

2023 Q3 Form 10-K Financial Statement

#000183437623000017 Filed on September 12, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$INNV InnovAge Holding Corp. Stock $innv

2023 Q3 Form 10-K Financial Statement

#000183437623000017 Filed on September 12, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$INNV
InnovAge Holding Corp. Stock $innv